Now Russia has approved a vaccine for novel coronavirus without the final phase of human trials. Russia has approved the vaccine for public use.
This vaccine is considered as the first vaccine which has been approved although china has made a vaccine much earlier but it has been used only for the People’s liberation army.
The vaccine created by Russia has created in Moscow-based Gamaleya institute. This vaccine has approved that it has clear regulatory in record time which is less than two months after it has got a human trial. This fact keeps raising concern about safety and its effect. But the other vaccine candidates in human trials are not expected to be ready before next year.
Talking about the production and availability of this vaccine it is not like this that only Gamaleya Institute owns this facility, this vaccine is produced by a plant that is owned by one of the biggest business groups of Russia and the name of that group is Sistema. Sistema has informed that the vaccine has the facility of producing around 1.5 million doses in a year, and soon this capacity will be increased.
But for those regions which are located outside Russia for those regions, it might take some time to facilitate the vaccine before the Russian vaccine is available. As reported by some news channel on Tuesday the sovereign wealth fund has requested 1 billion doses of the vaccine to serve the vaccine into other countries, and this international agreement has produced 500 million doses annually. till now the names of the countries have not been shown till yet.